Feed/Companies/Merida Biosciences

Merida Biosciences

As of 14 Oct 2026, Merida Biosciences has raised $121M across 1 verified round on record; latest: $121 million Series A led by Bain Capital Life Sciences, BVF Partners and 1 other, announced 8 Apr 2025.

BUILT ON

Visit site

Merida Biosciences develops precision therapies for autoimmune-driven diseases targeting pathogenic drivers of antibody-driven diseases.

meridabio.comBiotech

LATEST ROUND

Series A

$121M · 2025-04-08

RAISED ON RECORD · USD

$121M

across 1 verified round

INVESTORS

3 leads

SOURCES

from 2 publishers

Rounds

[ 1 ]

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$121M	2025-04-08	Bain Capital Life Sciences, BVF Partners, Third Rock Ventures	No recent discussion
2 sources [ VERIFIED ] read against 2 sources Sources agree. The Cambridge, Mass. dateline does not state the company's headquarters. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: meridabio.com, businesswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 2 sources·[ BRANDING ]logo and colour from the homepage

Merida Biosciences

Rounds

Company

Rounds

Sources

Profile

Investors

Merida Biosciences

Rounds

Profile

Sources

Series A$121M2025-04-082 sources

Investors

Series A$121M2025-04-085 investors